Skip to main content
RNA Biology logoLink to RNA Biology
. 2015 Feb 18;11(11):1340–1346. doi: 10.4161/15476286.2014.992283

Ribonucleotide triggered DNA damage and RNA-DNA damage responses

Bret D Wallace 1, R Scott Williams 1
PMCID: PMC4615641  PMID: 25692233

Abstract

Research indicates that the transient contamination of DNA with ribonucleotides exceeds all other known types of DNA damage combined. The consequences of ribose incorporation into DNA, and the identity of protein factors operating in this RNA-DNA realm to protect genomic integrity from RNA-triggered events are emerging. Left unrepaired, the presence of ribonucleotides in genomic DNA impacts cellular proliferation and is associated with chromosome instability, gross chromosomal rearrangements, mutagenesis, and production of previously unrecognized forms of ribonucleotide-triggered DNA damage. Here, we highlight recent findings on the nature and structure of DNA damage arising from ribonucleotides in DNA, and the identification of cellular factors acting in an RNA-DNA damage response (RDDR) to counter RNA-triggered DNA damage.

Keywords: Aprataxin, Aptx, RNase H2, Tyrosyl-DNA phosphodiesterase 2 (Tdp2), Topoisomerase 1 (Top1), Top1cc, Topoisomerase 2 (Top2), Top2cc, Flap Endonuclease 1 (FEN-1), DNA ligase, 2′-3′-cyclic PO4, Ribonucleotide Excision Repair (RER), abortive ligation, DNA adenylation, DNA damage, RNA-DNA damage, Genome Stability, DNA repair, Ataxia Oculomotor Apraxia, AOA1, Acardi-Goutieres syndrome

Abundant Incorporation of ribonucleotides into DNA

In articulating the general transfers of molecular biology: DNA → DNA, DNA → RNA, and RNA→ Protein, Francis Crick presciently noted that the proposed central dogma:

“ says nothing about what the machinery of transfer is made of, and in particular nothing about errors. (It was assumed that, in general, the accuracy of transfer was high.)."1

Nearly a half-century later, emerging data indicates that for DNA polymerases, the fidelity of the polymerization reaction (i. e. DNA → DNA) with respect to the nucleic acid sugar identity varies widely.2 Ribonucleotide incorporation into DNA is abundant and pervasive across phyla. It has been demonstrated to occur in prokaryotes (E. coli)3,4 yeasts (both Schizosaccharomyces pombe5 and Saccharomyces cerevisiae 2,6,7 and importantly, in vertebrate cells.8,9 Estimates for the budding yeast replicative polymerases suggest that on average ∼1/6500 polymerization events (∼13,000 rNMPs/genome) are completed using ribonucleotides, rather than deoxyribonucleotides.2,6,7 In mouse embryonic fibroblasts, it is estimated that greater than ∼1,300,000 ribonucleotides (approximately 1/7600 polymerization reactions) are introduced into the nuclear genome each cell division.8,9 Ribonucleotides are also utilized by the DNA repair polymerases μ and λ,10 as well as the mitochondrial DNA polymerase γ.11 Broadly speaking, ribonucleotides outnumber all other forms of abundant DNA damage including apurinic sites, oxidative DNA base damage (e.g. Eight-oxo guanine), and UV induced photoproducts (e.g., T-T dimers) (Fig. 1). In fact, when summed, the number of ribonucleotide incorporation events in cycling cells may exceed, by an order of magnitude, the total of all other known forms of DNA damage combined. How then, are ribonucleotides removed from the genome, and what are the consequences of harboring ribonucleotides in DNA? How is the potential for ribonucleotide triggered DNA damage circumvented, and what factors operate in this RNA-DNA realm to preserve genome integrity?

Figure 1.

Figure 1.

Ribonucleotides are an abundant form of DNA damage. Ribonucleotide incorporation in cycling cells is the most commonly observed insult to genomic DNA, with ∼1,000,000 ribonucleotide insertions observed in mammalian genomes8 and ∼13,000 budding yeast genomes.7 UV-induced damage including 6,4 photoproducts and thymine-thymine dimers are estimated to occur at high frequency, ∼105 per cell/day in keratinocytes.53,54 Apurinic (AP) sites from spontaneous depurination and base excision repair reactions occur at ∼30,000 APsites/cell/day.55 DNA base damage from reactive oxygen species (ROS) generates 8-oxoguanine, a common lesion with an abundance of ∼2,400 lesions/cell/day.55

Ribonucleotide excision repair (RER)

Like all abundant DNA damage, ribonucleotides in DNA are efficiently removed (Fig. 2A). A robust ribonucleotide removal pathway, now termed ribonucleotide excision repair or RER (see below), is initiated by the structure specific RNase H2 endoribonuclease. 7,8,9,12,13 Early work demonstrated that mammalian HeLa or Saccharomyces cerevisiae cell extracts can catalyze the in vitro endonucleolytic cleavage and excision of a single ribonucleotide embedded in an otherwise doubled-stranded DNA (dsDNA) substrate.13 Yeast lysates deficient in the catalytic subunit of RNase H2, RNH201, cannot catalyze incision 5′ of the ribonucleotide base, whereas rad27Δ strains deficient for the budding yeast flap endonuclease (FEN-1) homolog display impaired nucleolytic removal of the incised ribonucleotide. Consistent with a role in DNA repair, a budding yeast RNase H2 deficient strain has an increased spontaneous mutation rate, that is dominated by 2–5 bp deletions in repeat sequences.6,7,14,15 To further test the functional relevance of RNase H2 to ribonucleotide excision in vivo, Kunkel and coworkers7 engineered powerful genetic tools to facilitate manipulation of ribonucleotide levels in the budding yeast genome. In this approach, mutants of the leading strand replicative DNA polymerase ε (S. cerevisiae POL2) active site targeting a conserved hydrophobic residue adjacent to the polymerase “steric gate” were created that confer either increased or decreased propensity of the polymerase to utilize rNTPs (rather than dNTPs) during polymerization.7 Yeast strains with mutant POL2 have either elevated (pol2-M644G) or suppressed (pol2-M644L) levels of genomic ribonucleotides.6,7 Significantly, the rate of 2–5 bp deletions are highly elevated in a strain that harbors both an elevated ribonucleotide load, and a deficiency in RNase H2-directed RER (pol2-M644G rnh201Δ).6,7 Similar genetic relationships for polymerase active site mutants and RNase H2 have been observed in S. pombe.5 Genome maintenance roles for RNase H2 have also been established in mice. Mutational inactivation of mouse RNase H2 results in abnormal embryonic development, accumulation of single and double ribonucleotides in nuclear DNA of mouse embryonic fibroblasts, confers severe genome instability phenotypes including gross chromosomal rearrangements, and causes activation of a p53-dependant DNA damage response.8,9 Altogether, studies in yeasts and mice indicate that RNase H2 directed RER is critical for removal of DNA embedded ribonucleotides to prevent genomic instability.

Figure 2.

Figure 2.

Ribonucleotide incorporation by DNA polymerases into the genome creates insults that necessitate the need for multiple methods and repair enzymes for efficient removal. (A) RNase H2 cleavage initiates RER and generates 3′OH and 5′PO4-Ribo-DNA substrates. Abortive DNA ligation adenylates RER intermediates to generate adenylated-RNA-DNA lesions. Aprataxin catalyzes deadenylation of the 5′-AMP. When RNase H2 is deficient, topoisomerase I incision at a ribonucleotide creates unnatural ends consisting of a 5′OH and 3′Ribo-Top1 cleavage complex. Upon cyclization utilizing the available 2′OH of the ribonucleotide, a 2′-3′-cyclic-PO4 adduct is generated, similar to hydrolysis. Ribonucleotides stimulate Top2cc formation. Tdp2 repairs Top2-RNA/DNA complexes. (B) The crystal structure of a transition state mimic complex of Aprataxin bound to adenylated RNA-DNA (RCSB ID: 4NDG).25 The adenylated-RNA lesion is bound in A-form conformation, and completely encircled and aligned for the Aptx direct damage reversal reaction. (C) X-ray structure of T. maritima RNase H2 bound to an 5-RNA-DNA-3 junction (PDB ID: 4HHT).17 (D) The crystal structure of a Top1-DNA covalent complex (PDB ID: 1a31).32 A modeled 2′-OH is displayed, indicating active site rearrangement might be required to facilitate the 2′-3′-cycliclization reaction. (E) The structure of an RNA-DNA junction hybrid bound by mouse Tdp2 (PDB ID: 4PUQ).28 The 1.6 Å X-ray structure indicates the Tdp2 binding pocket accommodates RNA substrate, in a strained formation, for a single metal ion mediated phosphotyrosyl cleavage reaction. Glycerol occupies the approximate position of Top2 active site tyrosine residue.

Structure-function studies of RNase H2 homologs have also laid a detailed foundation for understanding the RNase H2 incision reaction.16,17 Early structures of Archaeoglobus fulgidus RNase H2 predicted that together a canonical RNase H fold, conserved tyrosine-finger (Y164) and helix-loop-helix domain would mediate interactions with the RNA-DNA.17 Subsequent X-ray structures of T. maritima RNase H2 bound to an RNA-DNA junction16 confirmed and extended these predictions, unveiling critical properties of RNA-DNA structure-specific substrate recognition (Fig. 2C). Notable interactions to the ribonucleotide 2-OH are stabilized by key interactions with the tyrosine finger (Y163 of T. maritima RNase H2) of the C-terminal domain that deforms the RNA/DNA backbone, facilitating a proposed substrate assisted catalytic mechanism.16 The tyrosine finger also participates in ring stacking interactions with the ribose sugar of the +2 position in the RNA-DNA junction, providing selectivity for cleavage at the RNA-DNA junction (Fig. 2C). By manipulating conserved elements of the RNA-DNA interaction observed in the X-ray structures, a mutant of budding yeast RNase H2 has been engineered that is unable to cleave single ribonucleotides in DNA but retains the ability to perform other RNase H2 dependent functions (e.g. degradation of RNA-DNA hybrids).18 This separation of function mutant allows for the correlation of 2–5 bp deletion mutants accumulated in rnh201Δ strains with single ribonucleotides embedded in DNA, and is thus supportive of RNase H2 RNA-DNA processing roles in the maintenance of genomic integrity in vivo.18

Ribonucleotide-triggered RNA-DNA Damage

Given the high abundance of ribonucleotide incorporation into DNA, it is also probable that some ribonucleotides escape RER. While differing by a only a single atom at the 2′-position, reactivity of the ribose 2-hydroxyl renders the sugar-phosphate backbone prone to hydrolysis reactions generating aberrant 5′-hydroxyl and 2′-3′-cyclic phosphate strand break termini (Fig. 2A).19 Ribonucleotides also induce distortions to surrounding local DNA helical structure,20,21 and alter elastic properties of nucleic acid.22 The differences in the structure and backbone reactivity of ribonucleotide-containing DNA can further induce differential processing of an RNA-DNA substrate by key nucleic acid metabolizing enzymes including DNA ligases,23-25 DNA topoisomerase 1 (Top1),15,26 and DNA topoisomerase 2 (Top2).27,28 We discuss these outcomes below.

Mutagenic Ribonucleotide Removal by Top1

Topoisomerase 1 (Top1) resolves DNA supercoils to facilitate replication and transcription.29,30 The Top1 incision-religation reaction cycle initiates with nucleophilic attack by an active site tyrosine on the DNA phosphodiester backbone to generate a transient and reversible Top1 cleavage complex (Top1cc) where Top1 is covalently linked to the 3′-terminal phosphate (Fig. 2A). On ribonucleotide containing substrates, however, Top1 can display strong endoribonuclease activity.15,26 Ribonucleotides create hot spots for the Top1 incision,15,26 and within the Top1 active site, the Top1cc is further prone to nucleophilic attack by the vicinal 2-OH of the ribonucleotide. This cyclization reaction generates a 5-OH and 2-3′-cyclic-PO4 products, rather than resealing of the phosphodiester backbone as in the canonical Top1 reaction.6,15,26,31 Inspection of the X-ray structure of human Top1cc,32 suggests that a significant rearrangement of Top1cc with a covalently linked 3′-ribonucleotide (modeled, Fig. 2D) would be required to facilitate the activation and alignment of the 2′-OH group for cyclization.

Intriguingly, in the absence of RNase H2, Top1 processing of ribonucleotides drives an alternative ribonucleotide excision repair pathway for removal of ribonucleotides from genomic DNA, albeit at a cost.6 In RNase H2-deficient yeast containing a high level of unrepaired ribonucleotides, Top1 processing of ribonucleotides causes activation of the intra S-phase checkpoint, replication stress, and the hallmark generation of 2–5 bp deletions in repetitive sequences.6,15,31 Following Top1 incision, the 5-side of the break can be processed by an Srs2-ExoI helicase-nuclease pathway.33 Yet, the precise downstream processing events that generate deletions remain to be determined in detail (see refs 6,33 for discussion). Also, the candidate processing enzyme(s) for resolving the 2′-3′-cyclic-PO4 ends has not been reported.

Repair of Ribonucleotide Linked Top2 Cleavage Complexes by Tdp2

The eukaryotic type II topoisomerases (Top2α and Top2β) regulate DNA topology by employing a dsDNA cleavage and religation cycle involving transient formation of Top2-DNA cleavage-complexes (Top2cc).34,35 Top2 catalytic intermediates are characterized by covalent linkage of the topoisomerase to the DNA 5-terminus by an active site tyrosine residue (Fig. 2A). However, aberrant DNA structure or targeted chemotherapeutic disruption of the Top2 reaction can generate Top2cc, protein-DNA crosslinks that block transcription and/or collapse DNA replication forks.29,30 Interestingly, ribonucleotides stimulate the Top2α and Top2β DNA cleavage reactions27 to produce Top2–RNA-DNA cleavage complexes.27,28 Ribonucleotides are therefore potentially toxic to the normal Top2 reaction cycle.

A major pathway for repair of Top2cc that is present in vertebrates, but absent in lower eukaryotes including yeasts, involves direct reversal of Top2-DNA phosphortyrosyl linkages by tyrosyl DNA phosphodiesterase 2 (Tdp2).36-38 Tdp2 (aka Ttrap/Eap2/VPg unlinkase) also catalyzes reversal of protein-RNA covalent linkages during RNA replication of picornaviruses (e.g., poliovirus and rhinovirus), suggestive of broader RNA repair functions for Tdp2.39 Recently, we demonstrated that Tdp2 also efficiently processes protease digestion fragments of Top2cc covalently adducted to 5 ribonucleotides.28 The high resolution structure of Tdp2 bound to a 5-ribonucleotide containing substrate further defines a mechanism through which RNA-containing substrates are engaged by Tdp2 in a manner similar to that of DNA-only substrates (Fig. 2E).40,41 Overall, in vitro results support the possibility that genomic instability triggered by ribonucleotides in DNA may also be mediated by formation of Top2–RNA-DNA cleavage complexes and production of DNA single strand and double strand breaks. Correspondingly Tdp2 may also protect from RNA-triggered Top2cc formation in vivo by acting as an RNA-DNA repair factor.

Adenylated RNA-DNA Repair by Aptx

Embedded ribonucleotides are not the only threats to genomic integrity. We hypothesized that abundant incised RER intermediates from RNase H2 cleavage might also impact frequently occurring DNA transactions.25 One example of this is DNA ligation. Eukaryotic ATP-dependent DNA ligases catalyze DNA nick sealing during DNA replication and repair with a 3 step mechanism involving active site adenylation of the ligase, adenylate transfer to the DNA 5-phosphate, and DNA nick sealing with release of AMP. However, when DNA ligases engage nicked DNA substrates with preexisting DNA damage, for instance an RNA-DNA junction from RER, DNA ligase can undergo “abortive ligation” where the enzyme dissociates prematurely from its substrate following DNA adenylation.42,43,44 In this context, rather than sealing a DNA nick to finalize DNA replication or repair, DNA ligase may exacerbate preexisting DNA damage by catalyzing further addition of bulky AMP adducts (Fig. 2A). RNA-DNA junctions arising from RER are indeed subject to abortive ligation by human DNA ligases 1 and 3.25 Thus, RER intermediates trigger ligation failure, and production of compounded DNA damage in the form of adenylated RNA-DNA lesions. The mechanism through which DNA ligase is impacted by ribonucleotides merits further investigation. This process might involve localized distortion of the DNA 5-terminus that impacts the ligase nick-sealing reaction and/or modulation of DNA ligase's ability to stably encircle and align the nick junction.

Aprataxin (Aptx) is a member of the histidine triad (HIT) family of nucleoside hydrolases, and catalyzes direct reversal of DNA 5-adenylation resulting from abortive ligation.25,42 Aptx therefore may be critical for genome stability in cells undergoing abortive ligation during RER. Consistent with a role for Aprataxin in metabolizing RNA derived damage, budding yeast cells with elevated genomic ribonucleotides that lack the Aptx homolog, Hnt3, display marked defects in cellular proliferation, activation of the S-phase DNA damage checkpoint, and are sensitive to the replication inhibitor hydroxyl urea (HU).25 These phenotypes are attenuated in an rnh201Δ background, supporting a model where Aptx is required for efficient repair of adenylated RNA-DNA junctions that arise from RNase H2 incision followed by abortive ligase metabolism. Human and yeast aprataxins all efficiently catalyze reversal of adenylated RNA-DNA in vitro.25 Further, a series of X-ray crystal structures of hAptx bound to adenylated RNA-DNA structures defines a molecular basis for adenylated RNA-DNA damage processing involving structure-specific A-form RNA-DNA recognition of the adenylated RNA 5 terminus, and encirclement of the lesion pyrophosphate linkage to facilitate deadenylation (Fig. 2B).

Conclusions and Outlook

More research is needed to define the impacts of ribonucleotides on human health. For example, to what extent does RNA-triggered DNA damage contribute to carcinogenesis? Given that Aptx45, RNase H246,47 and Tdp248 mutations are linked to neurological disease, how do ribonucleotides in DNA modulate these disease outcomes? Mutations of the genes encoding human RNase H2 subunits are all associated with the autosomal-recessive neuroinflammatory Aicardi-Goutières Syndrome (AGS).46 AGS phenotypes may be in part due to defective RER and the accumulation of endogenous ribonucleotides and added forms of RNA-triggered DNA damage (Fig. 2A). Human APTX mutations are linked to heritable progressive cerebellar degenerative disease Ataxia with Oculomotor Apraxia 1 (AOA1).45 The facts that disease-causing AOA1 mutants (e.g. the missense mutation K197Q) significantly impair RNA-DNA deadenylation and directly distort the Aptx substrate RNA-DNA binding pocket makes it tempting to speculate that RNA-triggered abortive ligation contributes to the neurodegenerative pathology in AOA1.25

We note that in addition to the variety of potentially deleterious impacts on genomic stability discussed herein, intriguing examples for functions of embedded nuclear ribonucleotides are coming to light. These include the stable incorporation of ribonucleotides into the nuclear genome that regulate the mating type switch in S. pombe49,50 and a role for ribonucleotides as a DNA strand discrimination signal in DNA mismatch repair.51,52 Undoubtedly, genome-wide mapping of distribution, composition, and stability of genomic ribonucleotides promises to illuminate new functions and vulnerabilities imparted by introduction of ribonucleotides into DNA.

In searching for unifying principles that define the impacts of ribonucleotides on DNA transactions, we find few. Rather, ribonucleotides unpredictably alter enzymatic transactions, with important implications for genome stability, function, and disease. Ribonucleotides can vary reaction rates and equilibrium (e.g., Top2cc formation), alter the reaction course of DNA metabolizing enzymes (e.g. conversion of Top1 to an RNA-DNA endonuclease), and turn key genome guardians into genome threats (e.g., RNAse H2-dependant triggering of abortive DNA ligation). The emerging structure/activity studies are revealing that genome maintenance direct reversal enzymes and nucleases can indeed cope with varying chemistries triggered by ribose incorporation. The active sites of enzymes such as Tdp2 and Aptx reveal these enzymes do not deselect ribose, but rather can effectively accommodate lesions arising in both DNA and RNA-DNA contexts. Similarly, broad substrate specificity of the RER nuclease FEN-1 dually accommodates both RNA- and DNA in its incised strand.56,57 As the lines between RNA and DNA worlds become blurred, we anticipate new exciting twists, and added RNA-DNA metabolizing enzymes to emerge as our understanding of the impacts of ribonucleotides on genome stability and function deepens.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

We thank J Williams, S Andres and D Appel for comments.

Funding

Our studies are supported by the NIH Intramural Program: National Institute of Environmental Health Sciences, 1Z01ES102765 to R.S.W.

References

  • 1. Crick F. Central dogma of molecular biology. Nature 1970; 227:561-3; PMID:4913914; http://dx.doi.org/ 10.1038/227561a0 [DOI] [PubMed] [Google Scholar]
  • 2. Nick McElhinny SA, Watts BE, Kumar D, Watt DL, Lundstrom EB, Burgers PM, Johansson E, Chabes A, Kunkel TA. Abundant ribonucleotide incorporation into DNA by yeast replicative polymerases. Proc Natl Acad Sci U S A 2010; 107:4949-54; PMID:20194773; http://dx.doi.org/ 10.1073/pnas.0914857107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. McDonald JP, Vaisman A, Kuban W, Goodman MF, Woodgate R. Mechanisms employed by Escherichia coli to prevent ribonucleotide incorporation into genomic DNA by Pol V. PLoS Genetics 2012; 8:e1003030; PMID:23144626; http://dx.doi.org/ 10.1371/journal.pgen.1003030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Shen Y, Koh KD, Weiss B, Storici F. Mispaired rNMPs in DNA are mutagenic and are targets of mismatch repair and RNases H. Nat Struct Mol Biol 2012; 19:98-104; http://dx.doi.org/ 10.1038/nsmb.2176 [DOI] [PubMed] [Google Scholar]
  • 5. Miyabe I, Kunkel TA, Carr AM. The major roles of DNA polymerases epsilon and delta at the eukaryotic replication fork are evolutionarily conserved. PLoS Genetics 2011; 7:e1002407; PMID:22144917; http://dx.doi.org/ 10.1371/journal.pgen.1002407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Williams JS, Smith DJ, Marjavaara L, Lujan SA, Chabes A, Kunkel TA. Topoisomerase 1-mediated removal of ribonucleotides from nascent leading-strand DNA. Mol Cell 2013; 49:1010-5; PMID:23375499; http://dx.doi.org/ 10.1016/j.molcel.2012.12.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Nick McElhinny SA, Kumar D, Clark AB, Watt DL, Watts BE, Lundstrom EB, Johansson E, Chabes A, Kunkel TA. Genome instability due to ribonucleotide incorporation into DNA. Nat Chem Biol 2010; 6:774-81; PMID:20729855; http://dx.doi.org/ 10.1038/nchembio.424 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Reijns MA, Rabe B, Rigby RE, Mill P, Astell KR, Lettice LA, Boyle S, Leitch A, Keighren M, Kilanowski F, et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 2012; 149:1008-22; PMID:22579044; http://dx.doi.org/ 10.1016/j.cell.2012.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Hiller B, Achleitner M, Glage S, Naumann R, Behrendt R, Roers A. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med 2012; 209:1419-26; PMID:22802351; http://dx.doi.org/ 10.1084/jem.20120876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Nick McElhinny SA, Ramsden DA. Polymerase mu is a DNA-directed DNA/RNA polymerase. Mol Cell Biol 2003; 23:2309-15; PMID:12640116; http://dx.doi.org/ 10.1128/MCB.23.7.2309-2315.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kasiviswanathan R, Copeland WC. Ribonucleotide discrimination and reverse transcription by the human mitochondrial DNA polymerase. J Biol Chem 2011; 286:31490-500; PMID:21778232; http://dx.doi.org/ 10.1074/jbc.M111.252460 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Sparks JL, Chon H, Cerritelli SM, Kunkel TA, Johansson E, Crouch RJ, Burgers PM. RNase H2-initiated ribonucleotide excision repair. Mol Cell 2012; 47:980-6; PMID:22864116; http://dx.doi.org/ 10.1016/j.molcel.2012.06.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Rydberg B, Game J. Excision of misincorporated ribonucleotides in DNA by RNase H (type 2) and FEN-1 in cell-free extracts. Proc Natl Acad Sci U S A 2002; 99:16654-9; PMID:12475934; http://dx.doi.org/ 10.1073/pnas.262591699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Chen JZ, Qiu J, Shen B, Holmquist GP. Mutational spectrum analysis of RNase H(35) deficient Saccharomyces cerevisiae using fluorescence-based directed termination PCR. Nucleic Acids Res 2000; 28:3649-56; PMID:10982888; http://dx.doi.org/ 10.1093/nar/28.18.3649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kim N, Huang SN, Williams JS, Li YC, Clark AB, Cho JE, Kunkel TA, Pommier Y, Jinks-Robertson S. Mutagenic processing of ribonucleotides in DNA by yeast topoisomerase I. Science 2011; 332:1561-4; PMID:21700875; http://dx.doi.org/ 10.1126/science.1205016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Rychlik MP, Chon H, Cerritelli SM, Klimek P, Crouch RJ, Nowotny M. Crystal structures of RNase H2 in complex with nucleic acid reveal the mechanism of RNA-DNA junction recognition and cleavage. Mol Cell 2010; 40:658-70; PMID:21095591; http://dx.doi.org/ 10.1016/j.molcel.2010.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Chapados BR, Chai Q, Hosfield DJ, Qiu J, Shen B, Tainer JA. Structural biochemistry of a type 2 RNase H: RNA primer recognition and removal during DNA replication. J Mol Biol 2001; 307:541-56; PMID:11254381; http://dx.doi.org/ 10.1006/jmbi.2001.4494 [DOI] [PubMed] [Google Scholar]
  • 18. Chon H, Sparks JL, Rychlik M, Nowotny M, Burgers PM, Crouch RJ, Cerritelli SM. RNase H2 roles in genome integrity revealed by unlinking its activities. Nucleic Acids Res 2013; 41:3130-43; PMID:23355612; http://dx.doi.org/ 10.1093/nar/gkt027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Li Y, Breaker RR. Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2'-Hydroxyl group. J Am Chem Soc 1999; 121:5364-72; http://dx.doi.org/ 10.1021/ja990592p [DOI] [Google Scholar]
  • 20. Ban C, Ramakrishnan B, Sundaralingam M. A single 2'-hydroxyl group converts B-DNA to A-DNA. Crystal structure of the DNA-RNA chimeric decamer duplex d(CCGGC)r(G)d(CCGG) with a novel intermolecular G-C base-paired quadruplet. J Mol Biol 1994; 236:275-85; PMID:7508984; http://dx.doi.org/ 10.1006/jmbi.1994.1134 [DOI] [PubMed] [Google Scholar]
  • 21. DeRose EF, Perera L, Murray MS, Kunkel TA, London RE. Solution structure of the Dickerson DNA dodecamer containing a single ribonucleotide. Biochemistry 2012; 51:2407-16; PMID:22390730; http://dx.doi.org/ 10.1021/bi201710q [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Chiu HC, Koh KD, Evich M, Lesiak AL, Germann MW, Bongiorno A, Riedo E, Storici F. RNA intrusions change DNA elastic properties and structure. Nanoscale 2014; 6:10009-17; PMID:24992674; http://dx.doi.org/ 10.1039/C4NR01794C [DOI] [PubMed] [Google Scholar]
  • 23. Rumbaugh JA, Murante RS, Shi S, Bambara RA. Creation and removal of embedded ribonucleotides in chromosomal DNA during mammalian Okazaki fragment processing. J Biol Chem 1997; 272:22591-9; PMID:9278414; http://dx.doi.org/ 10.1074/jbc.272.36.22591 [DOI] [PubMed] [Google Scholar]
  • 24. Pascal JM, O'Brien PJ, Tomkinson AE, Ellenberger T. Human DNA ligase I completely encircles and partially unwinds nicked DNA. Nature 2004; 432:473-8; PMID:15565146; http://dx.doi.org/ 10.1038/nature03082 [DOI] [PubMed] [Google Scholar]
  • 25. Tumbale P, Williams JS, Schellenberg MJ, Kunkel TA, Williams RS. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Nature 2014; 506:111-5; PMID:24362567; http://dx.doi.org/ 10.1038/nature12824 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Sekiguchi J, Shuman S. Site-specific ribonuclease activity of eukaryotic DNA topoisomerase I. Mol Cell 1997; 1:89-97; PMID:9659906; http://dx.doi.org/ 10.1016/S1097-2765(00)80010-6 [DOI] [PubMed] [Google Scholar]
  • 27. Wang Y, Knudsen BR, Bjergbaek L, Westergaard O, Andersen AH. Stimulated activity of human topoisomerases IIalpha and IIbeta on RNA-containing substrates. J Biol Chem 1999; 274:22839-46; PMID:10428869; http://dx.doi.org/ 10.1074/jbc.274.32.22839 [DOI] [PubMed] [Google Scholar]
  • 28. Gao R, Schellenberg MJ, Huang SY, Abdelmalak M, Marchand C, Nitiss KC, Nitiss JL, Williams RS, Pommier Y. Proteolytic Degradation of Topoisomerase II (Top2) Enables the Processing of Top2.DNA and Top2.RNA Covalent Complexes by Tyrosyl-DNA-Phosphodiesterase 2 (TDP2). J Biol Chem 2014; 289:17960-9; PMID:24808172; http://dx.doi.org/ 10.1074/jbc.M114.565374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Pommier Y, Huang SY, Gao R, Das BB, Murai J, Marchand C. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair 2014; 19:114-29; PMID:24856239; http://dx.doi.org/ 10.1016/j.dnarep.2014.03.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Pommier Y. Drugging topoisomerases: lessons and challenges. ACS Chem Biol 2013; 8:82-95; PMID:23259582; http://dx.doi.org/ 10.1021/cb300648v [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Cho JE, Kim N, Li YC, Jinks-Robertson S. Two distinct mechanisms of Topoisomerase 1-dependent mutagenesis in yeast. DNA Repair 2013; 12:205-11; PMID:23305949; http://dx.doi.org/ 10.1016/j.dnarep.2012.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Redinbo MR, Stewart L, Kuhn P, Champoux JJ, Hol WG. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 1998; 279:1504-13; PMID:9488644; http://dx.doi.org/ 10.1126/science.279.5356.1504 [DOI] [PubMed] [Google Scholar]
  • 33. Potenski CJ, Niu H, Sung P, Klein HL. Avoidance of ribonucleotide-induced mutations by RNase H2 and Srs2-Exo1 mechanisms. Nature 2014; 511:251-4; PMID:24896181; http://dx.doi.org/ 10.1038/nature13292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Nitiss JL. DNA topoisomerase II and its growing repertoire of biological functions. Nat Rev Cancer 2009; 9:327-37; PMID:19377505; http://dx.doi.org/ 10.1038/nrc2608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009; 9:338-50; PMID:19377506; http://dx.doi.org/ 10.1038/nrc2607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Gomez-Herreros F, Romero-Granados R, Zeng Z, Alvarez-Quilon A, Quintero C, Ju L, Umans L, Vermeire L, Huylebroeck D, Caldecott KW, et al. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo. PLoS Genetics 2013; 9:e1003226; PMID:23505375; http://dx.doi.org/ 10.1371/journal.pgen.1003226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Zeng Z, Cortes-Ledesma F, El Khamisy SF, Caldecott KW. TDP2/TTRAP is the major 5′-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. J Biol Chem 2011; 286:403-9; PMID:21030584; http://dx.doi.org/ 10.1074/jbc.M110.181016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW. A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 2009; 461:674-8; PMID:19794497; http://dx.doi.org/ 10.1038/nature08444 [DOI] [PubMed] [Google Scholar]
  • 39. Virgen-Slane R, Rozovics JM, Fitzgerald KD, Ngo T, Chou W, van der Heden van Noort GJ, Filippov DV, Gershon PD, Semler BL. An RNA virus hijacks an incognito function of a DNA repair enzyme. Proc Natl Acad Sci U S A 2012; 109:14634-9; PMID:22908287; http://dx.doi.org/ 10.1073/pnas.1208096109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Schellenberg MJ, Appel CD, Adhikari S, Robertson PD, Ramsden DA, Williams RS. Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2. Nat Struct Mol Biol 2012; 19:1363-71; PMID:23104055; http://dx.doi.org/ 10.1038/nsmb.2418 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Shi K, Kurahashi K, Gao R, Tsutakawa SE, Tainer JA, Pommier Y, Aihara H. Structural basis for recognition of 5'-phosphotyrosine adducts by Tdp2. Nat Struct Mol Biol 2012; 19:1372-7; PMID:23104058; http://dx.doi.org/ 10.1038/nsmb.2423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Ahel I, Rass U, El-Khamisy SF, Katyal S, Clements PM, McKinnon PJ, Caldecott KW, West SC. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 2006; 443:713-6; PMID:16964241; http://dx.doi.org/ 10.1038/nature05164 [DOI] [PubMed] [Google Scholar]
  • 43. Tumbale P, Appel CD, Kraehenbuehl R, Robertson PD, Williams JS, Krahn J, Ahel I, Williams RS. Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease. Nat Struct Mol Biol 2011; 18:1189-95; PMID:21984210; http://dx.doi.org/ 10.1038/nsmb.2146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Harris JL, Jakob B, Taucher-Scholz G, Dianov GL, Becherel OJ, Lavin MF. Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. Hum Mol Genet 2009; 18:4102-17; PMID:19643912; http://dx.doi.org/ 10.1093/hmg/ddp359 [DOI] [PubMed] [Google Scholar]
  • 45. Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, et al. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet 2001; 29:184-8; PMID:11586299; http://dx.doi.org/ 10.1038/ng1001-184 [DOI] [PubMed] [Google Scholar]
  • 46. Crow YJ, Leitch A, Hayward BE, Garner A, Parmar R, Griffith E, Ali M, Semple C, Aicardi J, Babul-Hirji R, et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genetics 2006; 38:910-6; PMID:16845400; http://dx.doi.org/ 10.1038/ng1842 [DOI] [PubMed] [Google Scholar]
  • 47. Reijns MA, Jackson AP. Ribonuclease H2 in health and disease. Biochem Soc Trans 2014; 42:717-25; PMID:25109948; http://dx.doi.org/ 10.1042/BST20140079 [DOI] [PubMed] [Google Scholar]
  • 48. Gomez-Herreros F, Schuurs-Hoeijmakers JH, McCormack M, Greally MT, Rulten S, Romero-Granados R, Counihan TJ, Chaila E, Conroy J, Ennis S, et al. TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function. Nat Genetics 2014; 46:516-21; PMID:24658003; http://dx.doi.org/ 10.1038/ng.2929 [DOI] [PubMed] [Google Scholar]
  • 49. Vengrova S, Dalgaard JZ. The wild-type Schizosaccharomyces pombe mat1 imprint consists of two ribonucleotides. EMBO Reports 2006; 7:59-65; PMID:16299470; http://dx.doi.org/ 10.1038/sj.embor.7400576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Vengrova S, Dalgaard JZ. RNase-sensitive DNA modification(s) initiates S. pombe mating-type switching. Genes Deve 2004; 18:794-804; PMID:15059961; http://dx.doi.org/ 10.1101/gad.289404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Lujan SA, Williams JS, Clausen AR, Clark AB, Kunkel TA. Ribonucleotides are signals for mismatch repair of leading-strand replication errors. Mol Cell 2013; 50:437-43; PMID:23603118; http://dx.doi.org/ 10.1016/j.molcel.2013.03.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Ghodgaonkar MM, Lazzaro F, Olivera-Pimentel M, Artola-Boran M, Cejka P, Reijns MA, Jackson AP, Plevani P, Muzi-Falconi M, Jiricny J. Ribonucleotides misincorporated into DNA act as strand-discrimination signals in eukaryotic mismatch repair. Mol Cell 2013; 50:323-32; PMID:23603115; http://dx.doi.org/ 10.1016/j.molcel.2013.03.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Setlow RB. DNA repair, aging, and cancer. Natl Cancer Inst Monogr 1982; 60:249-55; PMID:7121571 [PubMed] [Google Scholar]
  • 54. Hoeijmakers JH. DNA damage, aging, and cancer. New Engl J Med 2009; 361:1475-85; PMID:19812404; http://dx.doi.org/ 10.1056/NEJMra0804615 [DOI] [PubMed] [Google Scholar]
  • 55. Nakamura J, Mutlu E, Sharma V, Collins L, Bodnar W, Yu R, Lai Y, Moeller B, Lu K, Swenberg J. The endogenous exposome. DNA Repair 2014; 19:3-13; PMID:24767943; http://dx.doi.org/ 10.1016/j.dnarep.2014.03.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Tsutakawa SE, Classen S, Chapados BR, Arvai AS, Finger LD, Guenther G, Tomlinson CG, Thompson P, Sarker AH, Shen B, et al. Human flap endonuclease structures, DNA double-base flipping, and a unified understanding of the FEN1 superfamily. Cell 2011; 145:198-211; PMID:21496641; http://dx.doi.org/ 10.1016/j.cell.2011.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Tsutakawa SE, Lafrance-Vanasse J, Tainer JA. The cutting edges in DNA repair, licensing, and fidelity: DNA and RNA repair nucleases sculpt DNA to measure twice, cut once. DNA Repair 2014; 19:95-107; PMID:24754999; http://dx.doi.org/ 10.1016/j.dnarep.2014.03.022 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from RNA Biology are provided here courtesy of Taylor & Francis

RESOURCES